Found: 19
Select item for more details and to access through your institution.
Puerarin from Pueraria lobate attenuates ischemia‐induced cardiac injuries and inflammation in vitro and in vivo: The key role of miR‐130a‐5p/HMGB2 pathway.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 952, doi. 10.1111/cbdd.14204
- By:
- Publication type:
- Article
High therapeutic efficacy of 5‐Fluorouracil‐loaded exosomes against colon cancer cells.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 962, doi. 10.1111/cbdd.14205
- By:
- Publication type:
- Article
Ginsenoside Rg3 alleviates the migration, invasion, and angiogenesis of lung cancer cells by inhibiting the expressions of cyclooxygenase‐2 and vascular endothelial growth factor.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 937, doi. 10.1111/cbdd.14203
- By:
- Publication type:
- Article
Tetrandrine inhibits migration and invasion of BGC‐823 and MKN‐45 cells by regulating PI3K/AKT/mTOR signaling pathway.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 927, doi. 10.1111/cbdd.14202
- By:
- Publication type:
- Article
Polysaccharide‐modified liposomes and their application in cancer research.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 998, doi. 10.1111/cbdd.14201
- By:
- Publication type:
- Article
Detection of melatonin protective effects in sepsis via argyrophilic nucleolar regulatory region‐associated protein synthesis and TLR4/NF‐κB signaling pathway.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 915, doi. 10.1111/cbdd.14199
- By:
- Publication type:
- Article
Discovery and evaluation of biphenyl derivatives of 2‐iminobenzimidazoles as prototype dual PTP1B inhibitors and AMPK activators with in vivo antidiabetic activity.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 896, doi. 10.1111/cbdd.14198
- By:
- Publication type:
- Article
Myoinositol and methyl stearate increases rifampicin susceptibility among drug‐resistant Mycobacterium tuberculosis expressing Rv1819c.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 883, doi. 10.1111/cbdd.14197
- By:
- Publication type:
- Article
Molecular target interactions of quinoline derivatives as anticancer agents: A review.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 977, doi. 10.1111/cbdd.14196
- By:
- Publication type:
- Article
Two new dilactonized glycerol glycosides of the dual anticholinesterase active extract from Ocotea daphnifolia using bioguided fractionation and molecular docking studies.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 855, doi. 10.1111/cbdd.14195
- By:
- Publication type:
- Article
KH‐17, a simplified derivative of bongkrekic acid, weakly inhibits the mitochondrial ADP/ATP carrier from both sides of the inner mitochondrial membrane.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 865, doi. 10.1111/cbdd.14194
- By:
- Publication type:
- Article
Icaritin inhibits oxidative stress in murine astrocytes by binding to Orai1 to block store‐operated calcium channel.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 873, doi. 10.1111/cbdd.14193
- By:
- Publication type:
- Article
Protective effect of a mitochondria‐targeting peptide against paclitaxel‐induced peripheral neuropathy.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 1012, doi. 10.1111/cbdd.14192
- By:
- Publication type:
- Article
Orthogonal threading‐through‐β‐sheet design of lung cancer EGFR extracellular domain‐derived peptidic mimotopes binding to anti‐EGFR antibody.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 848, doi. 10.1111/cbdd.14188
- By:
- Publication type:
- Article
Combining computational and experimental evidence on the activity of antimalarial drugs on papain‐like protease of SARS‐CoV‐2: A repurposing study.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 809, doi. 10.1111/cbdd.14187
- By:
- Publication type:
- Article
Design and biological characterization of a series of dual mechanism ERK1/2 inhibitors with a Triazolopyridinone core.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 837, doi. 10.1111/cbdd.14186
- By:
- Publication type:
- Article
Quinoline‐based heterocyclic hydrazones: Design, synthesis, anti‐plasmodial assessment, and mechanistic insights.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 829, doi. 10.1111/cbdd.14185
- By:
- Publication type:
- Article
Salviolone protects against high glucose‐induced proliferation, oxidative stress, inflammation, and fibrosis of human renal mesangial cells by upregulating membrane metalloendopeptidase expression.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. 819, doi. 10.1111/cbdd.14183
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 101, n. 4, p. i, doi. 10.1111/cbdd.14074
- Publication type:
- Article